[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"total-laparoscopic-hysterectomy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:total-laparoscopic-hysterectomy":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,41,64],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100652362","routine-versus-selective-ureterolysis-during-total-laparoscopic-hysterectomy-for-benign-conditions-100652362",false,"NCT07774871","Routine Versus Selective Ureterolysis During Total Laparoscopic Hysterectomy for Benign Conditions","Routine Versus Selective Ureterolysis During Total Laparoscopic Hysterectomy for Benign Conditions: A Randomized Controlled Trial of Operative Efficiency and Perioperative Safety","Inclusion Criteria:\n\nWomen aged 35-70 years\n\nScheduled for TLH for benign indications:\n\nSymptomatic fibroids, Abnormal uterine bleeding, Adenomyosis, Endometrial hyperplasia, Pelvic organ prolapse requiring hysterectomy, Chronic pelvic pain, Uterine size ≤16 weeks\n\nExclusion Criteria:\n\n* Previous pelvic radiation\n* Known ureteric abnormalities or pathology\n* Severe cardiopulmonary disease precluding laparoscopy\n* Inability to provide informed consent\n* Known retroperitoneal pathology\n* Emergency surgery\n* Uterine size \\> 16 weeks","FEMALE","35 Years","70 Years",{"count":20,"type":21},100,"ESTIMATED","INTERVENTIONAL",[24],"NA","To evaluate whether routine ureterolysis during Total Laparoscopic Hysterectomy for benign gynecologic conditions affects operative efficiency and perioperative safety compared with a selective ureterolysis approach.",[27],"Total Laparoscopic Hysterectomy","NOT_YET_RECRUITING","2026-08-16",{"date":31,"type":32},"2026-08-19","ACTUAL",{"date":34,"type":21},"2026-08-21",{"date":36,"type":21},"2027-04-28",{"name":38,"class":39},"ClinAmygate","OTHER",1,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":4,"eligibilityCriteria":46,"healthyVolunteers":11,"sex":16,"minAge":47,"maxAge":4,"enrollmentInfo":48,"targetDuration":4,"studyType":22,"phases":50,"briefSummary":51,"conditions":52,"keywords":4,"overallStatus":54,"whyStopped":4,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":40},"100620827","effects-of-ultrasound-guided-recruitment-manoeuvres-on-postoperative-pulmonary-complications-in-osa-patients-undergoing-total-laparoscopic-hysterectomy-100620827","NCT07362680","Effects of Ultrasound-guided Recruitment Manoeuvres on Postoperative Pulmonary Complications in OSA Patients Undergoing Total Laparoscopic Hysterectomy","Inclusion Criteria:\n\n* Age ≥ 18 years;\n* Scheduled for elective total laparoscopic hysterectomy;\n* American Society of Anesthesiologists (ASA) I to III;\n* BMI \\> 28 kg\u002Fm²;\n* STOP-BANG score ≥ 3.\n\nExclusion Criteria:\n\n* Abnormal findings on preoperative chest X-ray or CT, such as atelectasis, pneumothorax, thoracic deformity, pleural effusion, or neuromuscular diseases;\n* Pre-existing severe pulmonary diseases;\n* Severe cardiac arrhythmias or a history of cardiac surgery;\n* Allergy to any medications used in the study.","18 Years",{"count":49,"type":21},90,[24],"This study aims to evaluate the lung-protective effects of ultrasound-guided lung recruitment maneuvers in patients with OSA undergoing total laparoscopic hysterectomy and to explore the efficacy of EELV measurement in assessing the effectiveness of these maneuvers.",[27,53],"Atelectasis, Postoperative","RECRUITING","2026-01-15",{"date":57,"type":32},"2026-01-23",{"date":59,"type":32},"2025-05-02",{"date":61,"type":21},"2026-08-31",{"name":63,"class":39},"The First Affiliated Hospital of Xinxiang Medical College",{"id":65,"slug":66,"hasResults":11,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":4,"eligibilityCriteria":70,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":71,"targetDuration":4,"studyType":22,"phases":73,"briefSummary":74,"conditions":75,"keywords":4,"overallStatus":54,"whyStopped":4,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":40},"100582769","laparoscopic-versus-transvaginal-closure-of-the-vaginal-vault-after-total-laparoscopic-hysterectomy-100582769","NCT06867614","Laparoscopic Versus Transvaginal Closure of the Vaginal Vault After Total Laparoscopic Hysterectomy","Laparoscopic Versus Transvaginal Closure of the Vaginal Vault After Total Laparoscopic Hysterectomy - a Single Blinded Randomized Comparative Study","Inclusion Criteria:\n\n* Adult females consenting to do TLH all age groups with diagnoses of benign uterine conditions.\n* Women who are non-obese (normal or overweight women with BMI range 18-29.9).\n* Sexually active female.\n\nExclusion Criteria:\n\n* Diagnosed cases of pelvic malignancy\n* Diagnosed patients with Cervical intraepithelial neoplasia (CIN) or bacterial vaginosis (any infection should be treated)\n* Obese patients.\n* Patients currently undergoing treatment for any type of cancer\n* Patients with coagulopathy, bleeding\u002Fclotting disorders\n* Patients with any condition can impair wound healing: diabetes mellites, anemia, steroids\n* Patients with a previous history of radiation and allergy to sutures\n* Patients with clinically evident prolapse",{"count":72,"type":21},48,[24],"The goal of this clinical trial is to compare the laparoscopic and transvaginal closure techniques of the vaginal vault in patients who perform TLH, regarding the risk of vaginal vault hematoma and other complications as vaginal cuff infection and sexual dysfunction.",[27],"2025-03-04",{"date":78,"type":32},"2025-03-10",{"date":80,"type":32},"2025-01-14",{"date":82,"type":21},"2026-01-19",{"name":84,"class":39},"Ain Shams University"]